Carmona BFI, Millalonco BFA, Marín CMJ, Álvarez CCV

Language: Spanish
References: 27
Page: 1-25
PDF size: 327.60 Kb.

ABSTRACT

Type 2 diabetes mellitus represents one of the main public health problems worldwide today. Among the main complications generated by this disease is diabetic retinopathy, which can lead to permanent vision loss. For this reason, research on treatments for this pathology is increasing. This is why treatments based on chemicals obtained from medicinal plants are widely investigated as they could provide a safer, less costly and less toxic alternative to standard medicine for the treatment of this eye disease of high incidence worldwide. The aim of this study was to identify the main phytochemicals with potential to be used as treatment for diabetic retinopathy. In order to achieve this purpose, a review of the literature published between January 2017 and June 2021 was conducted using the WOS, PUBMED and Scopus databases in English and Spanish, in order to compile updated scientific evidence on the use and impact of phytochemicals in diabetic retinopathy. Several families of useful phytochemicals were identified. Among these, the most common were those of phenolic origin, although less common were also found carotenoids, terpenes and blends consisting of various plant species and phytochemicals. Their mechanisms of action were also identified, the most common being suppression of vascular endothelial growth factor-mediated neovascularization, protection and restoration of the blood-retinal barrier, reduction in reactive oxygen species activity and anti-inflammatory effect. Given the evidence regarding the usefulness of phytochemicals for the treatment of diabetic retinopathy, further research should be conducted.

REFERENCES

1. Cheloni R, Gandolfi SA, Signorelli C, Odone A. Global prevalence of diabetic retinopathy: Protocol for a systematic review and meta-analysis. BMJ Open. 2019;9(3):2015-9. DOI: http://dx.doi.org/10.1136/bmjopen-2018-0221881.

2. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3):556-64. DOI: https://doi.org/10.2337/dc11-19092.

3. Rodríguez RBN, Río TM, Padilla GCM, Barroso LR, González PA, Fernández ML, et al. Prevalencia de la discapacidad visual en el adulto diabético en Cuba. Rev Cubana Oftalmol [Internet]. 2021 [acceso 19-07-2022]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086421762021000100010&lng=es3.

4. Parveen A, Kim JH, Oh BG, Subedi L, Khan Z, Kim SY. Phytochemicals: Target-based therapeutic strategies for diabetic retinopathy. Moleculas. 2018;23(7):1519-48. DOI: https://doi.org/10.3390/molecules230715194.

5. Ojha S, Balaji V, Sadek B, Rajesh M. Beneficial effects of phytochemicals in diabetic retinopathy: experimental and clinical evidence. Eur Rev Med Pharmacol Sci. 2017 [acceso 1/07/2022];21(11):2769-83. Disponible en: https://www.europeanreview.org/article/128995.

6. Delgado AM, Issaoui M, Chammem N. Analysis of Main and Healthy Phenolic Compounds in Foods. J AOAC Int. 2019;102(5):1356-64. DOI: https://doi.org/10.5740/jaoacint.19-01286.

7. Song W, Zhu Y wei. Chinese Medicines in Diabetic Retinopathy Therapies. Chin J Integr Med. 2019;25(4):316-20. DOI: https://doi.org/10.1007/s11655-017-2911-07.

8. Singh S, Kushwaha P, Gupta SK. Exploring the Potential of Traditional Herbs in the Management of Diabetic Retinopathy: An Overview. Drug Res (Stuttg). 2020 Jul;70(7):298-09. DOI https://doi.org/10.1055/a-1148-39508.

9. Vasant More S, Kim I-S, Choi D-K. Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy. Molecules. 2017 [acceso 1/07/2022];22(1):76-95. Disponible en: https://www.mdpi.com/1420-3049/22/1/769.

10. Mahmoud AM, Abd El-Twab SM, Abdel-Reheim ES. Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism. Eur J Nutr. 2017;56(4):1671-84. DOI: https://doi.org/10.1007/s00394-016-1214-010.

11. Ahmad I, Hoda M. Attenuation of diabetic retinopathy and neuropathy by resveratrol: Review on its molecular mechanisms of action. Life Sciences. 2020;245:117350. DOI: https://doi.org/10.1016/j.lfs.2020.11735011.

12. Kim CS, Kim J, Kim YS, Jo K, Lee YM, Jung DH, et al. Improvement in diabetic retinopathy through protection against retinal apoptosis in spontaneously diabetic torii rats mediated by ethanol extract of Osteomeles schwerinae C.K. Schneid. Nutrients. 2019;11(3):546-67. DOI: https://doi.org/10.3390/nu1103054612.

13. Kumar N, Goel N. Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol Reports. 2019;24:e00370. DOI: https://doi.org/10.1016/j.btre.2019.e0037013.

14. Kilari EK, Putta S. Delayed progression of diabetic cataractogenesis and retinopathy by Litchi chinensis in STZ-induced diabetic rats. Cutan Ocul Toxicol. 2017;36(1):52-9. DOI: https://doi.org/10.3109/15569527.2016.114461014.

15. Rossino MG, Casini G. Nutraceuticals for the Treatment of Diabetic Retinopathy. Nutrients. 2019 Apr 2;11(4):771-00. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520779/15.

16. Matos AL, Bruno DF, Ambrósio AF, Santos PF. The benefits of flavonoids in diabetic retinopathy. Nutrients. 2020;12(10):1-29. DOI: https://doi.org/10.3390/nu1210316916.

17. Zhang T, Mei X, Ouyang H, Lu B, Yu Z, Wang Z, et al. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy. J Nutr Biochem. 2019;65:1-14. DOI: https://doi.org/10.1016/j.jnutbio.2018.11.00617.

18. Mei X, Zhang T, Ouyang H, Lu B, Wang Z, Ji L. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy. Biochem Pharmacol. 2019;159:82-95. DOI: https://doi.org/10.1016/j.bcp.2018.11.01118.

19. Fathalipour M, Mahmoodzadeh A, Safa O, Mirkhani H. Puerarin as potential treatment in diabetic retinopathy. J HerbMed Pharmacol. 2020;9(2):105-11. DOI: https://doi.org/10.34172/jhp.2020.1419.

20. Fathalipour M, Fathalipour H, Safa O, Nowrouzi-Sohrabi P, Mirkhani H, Hassanipour S. The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review. Diabetes Metab Syndr Obes. 2020;13:2347-58. DOI: https://doi.org/10.2147/DMSO.S25578320.

21. Zeng T, Liu Z, Liu H, He W, Tang X, Xie L, et al. Exploring Chemical and Biological Space of Terpenoids. J Chem Inf Model. 2019;59(9):3667-78. DOI: https://doi.org/10.1021/acs.jcim.9b0044321.

22. Fang M, Wan W, Li Q, Wan W, Long Y, Liu H, et al. Asiatic acid attenuates diabetic retinopathy through TLR4/MyD88/NF-?B p65 mediated modulation of microglia polarization. Life Sci. 2021; 277:119567. DOI: https://doi.org/10.1016/j.lfs.2021.11956722.

23. Shi Q, Wang J, Cheng Y, Dong X, Zhang M, Pei C. Palbinone alleviates diabetic retinopathy in STZ-induced rats by inhibiting NLRP3 inflammatory activity. J Biochem Mol Toxicol. 2020;34(7):e22489. DOI: https://doi.org/10.1002/jbt.2248923.

24. Amato R, Rossino MG, Cammalleri M, Locri F, Pucci L, Dal Monte M, et al. Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy. Nutrients. 2018;5;10(12):1932. DOI: https://doi.org/10.3390/nu1012193224.

25. Zhang C, Xu Y, Tan HY, Li S, Wang N, Zhang Y, et al. Neuroprotective effect of He-Ying-Qing-Re formula on retinal ganglion cell in diabetic retinopathy. J Ethnopharmacol. 2018;25;214:179-89. DOI: https://doi.org/10.1016/j.jep.2017.12.01825.

26. Zhang T, Ouyang H, Mei X, Lu B, Yu Z, Chen K, et al. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-?B signaling pathway. FASEB J Off Publ Fed Am Soc Exp Biol. 2019;33(11):11776-90. DOI: https://doi.org/10.1096/fj.201802614RRR26.

27. Xu X, Cai Y, Yu Y. Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats. Exp Ther Med. 2018;16(1):305-9. DOI: https://doi.org/10.3892/etm.2018.616727.